Alvaro Alencar, Md

This study is testing a combination of two drugs, zanubrutinib and tafasitamab, in people with mantle cell lymphoma, a rare blood cancer. The first part of the trial will find the best dose of zanubrutinib when used with tafasitamab. The second part will see how well the combinat…